FBIO Latest Press Releases

-- November 10, 2026 --

Fortress Biotech Announces an Exclusive License Agreement for FB-607 for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) Globe Newswire 4:05 PM

-- November 5, 2026 --

Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026 Globe Newswire 8:30 AM

-- September 8, 2026 --

Journey Medical Corporation to Participate in September 2026 Investor Conferences Globe Newswire 4:05 PM

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 8:00 AM

-- August 13, 2026 --

Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- August 12, 2026 --

Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM

-- August 7, 2026 --

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Fortress Biotech, Inc. (NASDAQ: FBIO) PRNewswire 12:45 PM

-- August 5, 2026 --

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 Globe Newswire 8:30 AM

-- July 27, 2026 --

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $130 Million Series B Financing Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes